Thermo Fisher Scientific Inc. (ETR:TN8)

Market Cap	191.44B
Revenue (ttm)	37.40B
Net Income (ttm)	5.62B
Shares Out	n/a
EPS (ttm)	14.81
PE Ratio	34.07
Forward PE	24.55
Dividend	1.51 (0.30%)
Ex-Dividend Date	Sep 15, 2025

Volume	184
Average Volume	217
Open	512.90
Previous Close	511.00
Day's Range	507.60 - 512.90
52-Week Range	336.25 - 590.90
Beta	n/a
RSI	60.65
Earnings Date	Jan 29, 2026

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 125,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: TN8

Financial Performance

In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.

Financial numbers in USD